Townsquare Capital LLC Biogen Inc. Transaction History

Townsquare Capital LLC

$7.19 Billion
Q2 2024

A detailed history of Townsquare Capital LLC transactions in Biogen Inc. stock. As of the latest transaction made, Townsquare Capital LLC holds 13,749 shares of BIIB stock, worth $2.39 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

13,749

Previous 13,837 0.64%

Holding current value

$2.39 Million

Previous $2.98 Million 6.84%

% of portfolio

0.04%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $16,765 - $20,831	-88 Reduced 0.64%	13,749 $3.19 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $358,101 - $452,162	-1,689 Reduced 10.88%	13,837 $2.98 Million
Q4 2023 Feb 15, 2024	SELL	$222.59 - $267.94 $169,390 - $203,902	-761 Reduced 4.67%	15,526 $4.02 Million
Q3 2023 Nov 15, 2023	SELL	$253.3 - $285.89 $143,874 - $162,385	-568 Reduced 3.37%	16,287 $4.19 Million
Q2 2023 Nov 13, 2023	BUY	$275.25 - $318.06 $462,970 - $534,976	1,682 Added 11.09%	16,855 $4.8 Million
Q1 2023 May 11, 2023	BUY	$256.56 - $292.34 $23,090 - $26,310	90 Added 0.6%	15,173 $4.22 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $460,703 - $559,764	1,825 Added 13.77%	15,083 $4.18 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $134,530 - $185,505	691 Added 5.5%	13,258 $3.54 Million
Q2 2022 Aug 08, 2022	BUY	$187.54 - $223.02 $110,461 - $131,358	589 Added 4.92%	12,567 $2.56 Million
Q1 2022 Apr 28, 2022	BUY	$193.77 - $244.14 $560,770 - $706,541	2,894 Added 31.86%	11,978 $2.52 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $101,883 - $130,935	-455 Reduced 4.77%	9,084 $2.18 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $328,551 - $428,467	1,161 Added 13.86%	9,539 $2.7 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $345,765 - $553,637	1,335 Added 18.95%	8,378 $2.89 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $369,526 - $432,922	1,521 Added 27.54%	7,043 $1.97 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $26,697 - $40,186	-113 Reduced 2.01%	5,522 $1.35 Million
Q3 2020 Dec 01, 2020	BUY	$264.77 - $305.71 $278,008 - $320,995	1,050 Added 22.9%	5,635 $1.58 Million
Q2 2020 Aug 17, 2020	BUY	$258.66 - $342.55 $241,847 - $320,284	935 Added 25.62%	4,585 $1.27 Million
Q1 2020 May 18, 2020	BUY	$268.85 - $341.04 $388,488 - $492,802	1,445 Added 65.53%	3,650 $1.07 Million
Q4 2019 May 18, 2020	BUY	$220.06 - $304.07 $53,694 - $74,193	244 Added 12.44%	2,205 $654,000
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $230,921 - $259,000	1,062 Added 118.13%	1,961 $563,000
Q2 2019 Aug 15, 2019	BUY	$219.29 - $241.72 $197,141 - $217,306	899 New	899 $218,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Townsquare Capital LLC with notifications on news.

Account

Townsquare Capital LLC Biogen Inc. Transaction History